Catalyst Wire Dossier Catalyst Wire Dossier

KRINTAFEL

tafenoquine succinate · GlaxoSmithKline LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KRINTAFEL, covering 2017-06-12 to 2020-11-16. Get the full timeline:

Most recent: FDA Approved: KRINTAFEL — Supplemental Application (GlaxoSmithKline LLC)

See pricing